Motive Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
934
+4
+0.4% +$4.09K 0.46% 35
2026
Q1
$855K Sell
930
-8
-0.9% -$8.11K 0.4% 35
2025
Q4
$1.01M Buy
938
+7
+0.8% +$6.69K 0.43% 35
2025
Q3
$710K Sell
931
-1
-0.1% -$744 0.31% 36
2025
Q2
$727K Buy
932
+87
+10% +$67.6K 0.33% 36
2025
Q1
$698K Sell
845
-29
-3% -$24.1K 0.37% 34
2024
Q4
$675K Buy
874
+70
+9% +$58K 0.36% 37
2024
Q3
$728K Hold
804
0.44% 32
2024
Q2
$728K Buy
804
+3
+0.4% +$2.4K 0.44% 32
2024
Q1
$623K Buy
801
+285
+55% +$203K 0.38% 35
2023
Q4
$301K Sell
516
-174
-25% -$102K 0.35% 35
2023
Q3
$371K Sell
690
-46
-6% -$23.7K 0.41% 32
2023
Q2
$345K Buy
736
+8
+1% +$3.35K 0.36% 36
2023
Q1
$250K Sell
728
-73
-9% -$24.6K 0.27% 47
2022
Q4
$293K Buy
801
+91
+13% +$32.3K 0.22% 48
2022
Q3
$230K Buy
+710
New +$225K 0.19% 51

Other funds holding LLY

Motive Wealth Advisors's LLY Position: Q2 2026 in Review

Motive Wealth Advisors increased its Eli Lilly (LLY) stake by 0.43% in Q2 2026, buying an estimated $4.09K and bringing the position to 934 shares worth $1.12M. The position accounts for 0.46% of the portfolio, ranked #35.

Motive Wealth Advisors first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 1,103 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Motive Wealth Advisors held 934 shares of Eli Lilly worth $1.12M as of Q2 2026.
  • Motive Wealth Advisors bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.46% of Motive Wealth Advisors's portfolio in Q2 2026, its #35 holding.
  • Motive Wealth Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 1,103 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Motive Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.